Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) fell 6.8% on Thursday. The company traded as low as $34.91 and last traded at $35.0460. Approximately 543,225 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 2,821,889 shares. The stock had previously closed at $37.59.
Recent Acadia Healthcare Headlines
Investors following ACHC have been watching these headlines:
- Positive Sentiment: Zacks also lifted estimates for several individual quarters, including Q4 2026 to $0.35 EPS from $0.27 and Q3 2028 to $0.65 from $0.62, adding to the broadly improved earnings outlook.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on ACHC. Wall Street Zen upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Zacks Research upgraded shares of Acadia Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 9th. Raymond James Financial assumed coverage on shares of Acadia Healthcare in a report on Wednesday, November 4th. They issued a “moderate buy” rating on the stock. Royal Bank Of Canada upped their price target on Acadia Healthcare from $31.00 to $41.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Finally, Barclays increased their price target on Acadia Healthcare from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 5th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $32.54.
Check Out Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Trading Down 6.7%
The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 1.60. The business has a 50-day simple moving average of $31.04 and a two-hundred day simple moving average of $27.10. The stock has a market cap of $3.26 billion, a price-to-earnings ratio of -2.80, a P/E/G ratio of 4.76 and a beta of 0.64.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.07%. The company had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. During the same period in the previous year, the company posted $0.72 EPS. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.74 EPS for the current fiscal year.
Institutional Trading of Acadia Healthcare
Hedge funds and other institutional investors have recently modified their holdings of the stock. Allworth Financial LP lifted its holdings in Acadia Healthcare by 49.2% during the 3rd quarter. Allworth Financial LP now owns 2,254 shares of the company’s stock worth $62,000 after purchasing an additional 743 shares during the last quarter. Ares Systematic Credit Ltd acquired a new stake in shares of Acadia Healthcare during the third quarter worth $547,000. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 27.9% in the third quarter. Goldman Sachs Group Inc. now owns 3,674,399 shares of the company’s stock valued at $101,046,000 after acquiring an additional 802,271 shares during the period. GW&K Investment Management LLC grew its stake in shares of Acadia Healthcare by 5.4% in the third quarter. GW&K Investment Management LLC now owns 399,041 shares of the company’s stock valued at $10,974,000 after acquiring an additional 20,390 shares in the last quarter. Finally, Landscape Capital Management L.L.C. bought a new position in Acadia Healthcare during the third quarter worth about $741,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
Read More
- Five stocks we like better than Acadia Healthcare
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
